We aim to share scientific findings through a comprehensive publication process with:
Rapamycin Press, the new publishing division of Impact Journals, LLC, will continue bringing you Aging, Oncotarget, Oncosience and Genes & Cancer. We host a team of experts in scholary publishing and provide unrivaled services, resulting in world-renowned success of our journals.
Aging, launched in 2009, publishes papers of general interest and biological significance in all fields of aging research as well as covers topics beyond traditional gerontology
Oncotarget, launched in 2010, is twice-weekly, peer-reviewed, multidisciplinary traditional journal with open-access, covering research on all aspects of oncology and publishing sub-sections on topics beyond oncology such as aging, pathology (beyond oncology), immunology and microbiology, autophagy and cell death, chromosome and more.
Oncoscience, launched in 2014, covers the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. Oncoscience also has a special mission: Freeing oncology from publication cost. It is free for the readers and the authors.
Genes & Cancer, formerly a SAGE publication, was acquired in 2014 and covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, their role in signal transduction and the mechanisms by which their expression and function are altered during tumor development.